ETHZilla Corporation (ETHZ)

NASDAQ: ETHZ · Real-Time Price · USD
2.310
-0.110 (-4.55%)
At close: Sep 5, 2025, 4:00 PM
2.290
-0.020 (-0.87%)
After-hours: Sep 5, 2025, 7:59 PM EDT
-4.55%
Market Cap384.91M
Revenue (ttm)n/a
Net Income (ttm)-17.22M
Shares Out 166.63M
EPS (ttm)-6.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,232,303
Open2.500
Previous Close2.420
Day's Range2.221 - 2.540
52-Week Range0.658 - 17.750
Beta0.39
Analystsn/a
Price Targetn/a
Earnings DateOct 26, 2025

About ETHZ

ETHZilla Corporation, a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States. The company product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren’s Contracture; and Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close ... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Lloyd Jordan
Employees 4
Stock Exchange NASDAQ
Ticker Symbol ETHZ
Full Company Profile

Financial Performance

Financial Statements

News

ETHZilla Plans to Deploy $100 Million in ETH to EtherFi for Restaking Initiatives

Partnership marks ETHZilla's first engagement with DeFi protocols Company has accumulated 102,246 ETH at an average acquisition price of $3,948.72, valued at approximately $456 million PALM BEACH, Fla...

5 days ago - PRNewsWire

Bitcoin erases summer gains, crypto treasury stocks fall in August

CNBC's MacKenzie Sigalos joins "Closing Bell" to report on bitcoin giving up its summer gains, ether finishing the month higher, and muted ETF inflows.

Other symbols: BMNRMSTRSBET
9 days ago - CNBC Television

New Ether Treasury ETHZilla Stock Jumps on Buyback Program

Shares of ETHZilla (ETHZ) soared 9% Monday as the cryptocurrency treasury firm announced an up to $250 million stock repurchase plan and gave an update on its holding of Ether.

13 days ago - Investopedia

ETHZilla announces authorization of $250 million stock repurchase program

Company has accumulated 102,237 ETH at an average acquisition price of $3,948.72, which is now valued at approximately $489 million Announces implementation of proprietary Electric Asset Protocol to g...

13 days ago - PRNewsWire

Crypto Treasury stocks see pullback in August

CNBC's Tanaya Macheel joins 'Closing Bell Overtime' to break down why crypto treasuries have seen dramatic pull backs in August.

Other symbols: BMNRBNCMSTR
18 days ago - CNBC Television

ETHZilla Unveils New Brand Committed to Advancing Ethereum Treasury Strategy

Company announces new ticker (formally ATNF) and will begin trading on NASDAQ under ETHZ on August 18, 2025 Company has accumulated 94,675 ETH at an average acquisition price of $3,902.20, which is no...

20 days ago - PRNewsWire

Stock Market Today: S&P 500, Nasdaq 100 Futures Trade Mixed— UnitedHealth, 180 Life Sciences, Intel In Focus

U.S. stock futures were fluctuating on Friday following Thursday's mixed moves. Futures of major benchmark indices were mixed.

23 days ago - Benzinga

180 Life Sciences (ETHZilla) Holds 82,186 ETH

Company Initiates Institutional ETH Accumulation Strategy PALO ALTO, Calif. , Aug. 12, 2025 /PRNewswire/ -- 180 Life Sciences Corp. (Nasdaq: ATNF), dba ETHZilla (the "Company", "180 Life Sciences" or ...

26 days ago - PRNewsWire

180 Life Sciences Announces Closing of Private Offering of Approximately $156 Million of Convertible Notes

Company intends to use the net proceeds from this financing primarily to rapidly increase its ETH holdings This milestone follows the announcement of the Company's recently closed $425 million private...

27 days ago - PRNewsWire

180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury Strategy

Company intends to use the net proceeds from this financing primarily to rapidly increase its ETH holdings Company plans to execute a differentiated yield generation program, with Company built for th...

4 weeks ago - PRNewsWire

180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch ETHZilla

180 Life Sciences announces entry into PIPE funding documents to raise $425 million in gross proceeds to launch next generation Ethereum treasury strategy and planned rebranding to ETHZilla PALO ALTO,...

5 weeks ago - PRNewsWire

180 Life Sciences Corp. Announces Strengthening of Legacy Intellectual Property Assets

PALO ALTO, CA / ACCESS Newswire / July 1, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180" or the "Company), an innovative biotechnology company that is currently pivoting to the global iGaming sec...

2 months ago - Accesswire

180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction

PALO ALTO, CA / ACCESS Newswire / May 1, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), an innovative media and entertainment company focused on the global iGamin...

4 months ago - Accesswire

180 Life Sciences Corp. Announces Share Repurchase

PALO ALTO, CALIFORNIA / ACCESS Newswire / April 30, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences," the "Company," "we," or "us") today announced that it has entered into a Settleme...

4 months ago - Accesswire

180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules

PALO ALTO, CA / ACCESSWIRE / December 27, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international ...

9 months ago - Accesswire

180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules

PALO ALTO, CA / ACCESSWIRE / December 12, 2024 / 180 Life Sciences Corp. ("180" or the "Company") is pleased to announce that it has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requ...

9 months ago - Accesswire

180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors

PALO ALTO, CA / ACCESSWIRE / December 4, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international e...

9 months ago - Accesswire

180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration

PALO ALTO, CA / ACCESSWIRE / October 31, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the retention of Mr. Vaclav Vincalek as Senior Technology Consultant.

11 months ago - Accesswire

180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors

PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the appointment of Mr. Jay Goodman to its Board of Directors, effective i...

11 months ago - Accesswire

This biotech stock soared a whopping 900% on Wednesday: here's why

180 Life Sciences Corp (NASDAQ: ATNF), a biotech firm, saw its shares skyrocket by 900% on Wednesday following the acquisition of a blockchain-enabled platform. This strategic move marks a significant...

11 months ago - Invezz

180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform

PALO ALTO, CA / ACCESSWIRE / October 16, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF)("180" or the "Company"), today released the following letter to stockholders from its Interim Chief Executive Offi...

11 months ago - Accesswire

180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector

PALO ALTO, CA / ACCESSWIRE / October 9, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF) (the "Company" or "180"), is pleased to announce that it has received confirmation from Nasdaq that the Company has...

11 months ago - Accesswire

180 Life Sciences Corp. - Corporate Updates

Announcing Acquisition of Advanced Gaming Technology Platform, Positive Progress on Legacy CBD Formulation, and Strengthened Balance Sheet PALO ALTO, CA / ACCESSWIRE / October 3, 2024 / 180 Life Scien...

1 year ago - Accesswire

180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer

PALO ALTO, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (“180” or the “Company”) is pleased to announce the appointment of Omar Jimenez as its new Chief Financial Officer, effect...

1 year ago - GlobeNewsWire

180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake

PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced...

1 year ago - GlobeNewsWire